# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 5oiu:A (2.44) | BS01 | ATP | ? | N/A | Q5SLC9 | 30232337 | |
2 | 5oiu:A (2.44) | BS02 | ZN | ? | N/A | Q5SLC9 | 30232337 | |
3 | 5oiu:B (2.44) | BS01 | ATP | ? | N/A | Q5SLC9 | 30232337 | |
4 | 5oiu:B (2.44) | BS02 | ZN | ? | N/A | Q5SLC9 | 30232337 | |
5 | 5oiu:C (2.44) | BS01 | ATP | ? | N/A | Q5SLC9 | 30232337 | |
6 | 5oiu:C (2.44) | BS02 | ZN | ? | N/A | Q5SLC9 | 30232337 | |
7 | 5oiu:D (2.44) | BS01 | ATP | ? | N/A | Q5SLC9 | 30232337 | |
8 | 5oiu:D (2.44) | BS02 | ZN | ? | N/A | Q5SLC9 | 30232337 | |
9 | 5oiu:E (2.44) | BS01 | ATP | ? | N/A | Q5SLC9 | 30232337 | |
10 | 5oiu:E (2.44) | BS02 | MG | ? | N/A | Q5SLC9 | 30232337 | |
11 | 5oiu:E (2.44) | BS03 | ZN | ? | N/A | Q5SLC9 | 30232337 | |
12 | 5oiu:F (2.44) | BS01 | ATP | ? | N/A | Q5SLC9 | 30232337 | |
13 | 5oiu:F (2.44) | BS02 | ZN | ? | N/A | Q5SLC9 | 30232337 |